Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enfuvirtide QD vs BID with Raltegravir in HIV-1
NCT00488059Phase 4Terminated
- Sponsor
- Roche
- Start
- Jun 2007
- Primary completion
- Oct 2008
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 4 trial of enfuvirtide in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Roche. Started Jun 2007; status: terminated.
02
Drugs
enfuvirtide
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00488059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00488059.